Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing drug discovery and development activities
3.2.1.2 Advancements in biotechnology and life sciences research
3.2.1.3 Rising cases of chronic and infectious diseases
3.2.2 Industry pitfalls & challenges
3.2.2.1 High initial investment cost
3.2.2.2 Complexity and technical expertise requirements
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Technology, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Surface plasmon resonance
5.3 Bio-layer interferometry
5.4 Cellular dielectric spectroscopy
5.5 Microcantilever
5.6 Scanning kelvin nanoprobe
5.7 Enthalpy array
5.8 Atomic force microscopy
5.9 Other technologies
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Drug discovery
6.3 Protein interface analysis
6.4 Antibody characterization and development
6.5 Protein complex and cascade analysis
6.6 Detection of disease biomarkers
6.7 Other applications
Chapter 7 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Pharmaceutical & biotechnology companies
7.3 Academic & research institutes
7.4 Contract research organizations
7.5 Hospitals and clinics
7.6 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Agilent Technologies, Inc.
9.2 Becton, Dickinson and Company
9.3 Bio-Rad Laboratories, Inc.
9.4 Corning Incorporated
9.5 Danaher Corporation
9.6 F. Hoffmann-La Roche AG
9.7 Illumina, Inc.
9.8 Merck KGaA
9.9 Meso Scale Diagnostics (MSD)
9.10 Nanion Technologies
9.11 Pall Corporation
9.12 PerkinElmer, Inc.
9.13 Sartorius AG
9.14 Siemens Healthineers AG
9.15 Thermo Fisher Scientific Inc.
